GABAA Receptor-Modulating Steroids in Relation to Women’s Behavioral Health-Reference-Cited by-同舟云学术

GABAA Receptor-Modulating Steroids in Relation to Women’s Behavioral Health

Published:2015-09-23 Issue:11 Volume:17 Page:
ISSN:1523-3812
Container-title:Current Psychiatry Reports
language:en
Short-container-title:Curr Psychiatry Rep

Author:

Bäckström Torbjörn,Bixo Marie,Strömberg Jessica

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1007/s11920-015-0627-4.pdf

Reference63 articles.

1. Nyberg S, Backstrom T, Zingmark E, Purdy RH, Poromaa IS. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Gynecol Endocrinol. 2007;23(5):257–66.

2. Innala E, Backstrom T, Poromaa IS, Andersson C, Bixo M. Women with acute intermittent porphyria have a defect in 5alpha-steroid production during the menstrual cycle. Acta Obstet Gynecol Scand. 2012;91(12):1445–52.

3. Ottander U, Poromaa IS, Bjurulf E, Skytt A, Bäckström T, Olofsson JI. Allopregnanolone and pregnanolone are produced by the human corpus luteum. Mol Cell Endocrinol. 2005;239(1-2):37–44.

4. American Psychiatric Association D-, Diagnostic and statistical manual of mental disorders (DSM-5). 2013: American Psychiatric Publishing.

5. ACOG American College of Obstetricians and Gynecologists, ACOG practice bulletin. Premenstrual syndrome. nternational Journal of Gynecology & Obstetrics. 2001;73:183-–191.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes;Neuroscience & Biobehavioral Reviews;2024-09

2. Differential effects of perigestational consumption of sucrose‐sweetened beverages on anxiety and depression‐related behaviors in adult offspring: Sex disparity in a mouse model;International Journal of Developmental Neuroscience;2024-05-30

3. Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review;Diabetes Therapy;2024-04-26

4. Neuroactive steroid hormone trajectories across the menstrual cycle in premenstrual dysphoric disorder (PMDD): the PHASE study;Molecular Psychiatry;2024-04-25

5. Management of Premenstrual Dysphoric Disorder: A Scoping Review;Focus;2024-01